GIGLI, MARTA
 Distribuzione geografica
Continente #
NA - Nord America 4.816
EU - Europa 3.251
AS - Asia 2.642
SA - Sud America 338
Continente sconosciuto - Info sul continente non disponibili 312
AF - Africa 84
OC - Oceania 5
Totale 11.448
Nazione #
US - Stati Uniti d'America 4.701
IT - Italia 989
SG - Singapore 983
PL - Polonia 739
CN - Cina 596
DE - Germania 319
VN - Vietnam 274
BR - Brasile 257
HK - Hong Kong 214
SE - Svezia 191
NL - Olanda 178
FR - Francia 165
BD - Bangladesh 159
FI - Finlandia 144
GB - Regno Unito 141
KR - Corea 130
RU - Federazione Russa 79
IN - India 68
CA - Canada 63
TR - Turchia 51
IE - Irlanda 47
UA - Ucraina 47
BG - Bulgaria 44
MA - Marocco 34
AR - Argentina 32
CH - Svizzera 31
JP - Giappone 29
ES - Italia 28
MX - Messico 24
AT - Austria 21
ID - Indonesia 18
ZA - Sudafrica 18
BE - Belgio 17
IQ - Iraq 16
PK - Pakistan 16
RO - Romania 16
AE - Emirati Arabi Uniti 11
CO - Colombia 11
SA - Arabia Saudita 11
CL - Cile 10
EC - Ecuador 9
GR - Grecia 9
RS - Serbia 9
KE - Kenya 8
LV - Lettonia 8
VE - Venezuela 8
CR - Costa Rica 7
IL - Israele 7
TW - Taiwan 7
JO - Giordania 6
EG - Egitto 5
KG - Kirghizistan 5
PH - Filippine 5
TT - Trinidad e Tobago 5
AU - Australia 4
BO - Bolivia 4
DK - Danimarca 4
EU - Europa 4
JM - Giamaica 4
LB - Libano 4
PT - Portogallo 4
SK - Slovacchia (Repubblica Slovacca) 4
SN - Senegal 4
TH - Thailandia 4
AZ - Azerbaigian 3
CZ - Repubblica Ceca 3
HU - Ungheria 3
KZ - Kazakistan 3
LT - Lituania 3
NP - Nepal 3
OM - Oman 3
PY - Paraguay 3
UY - Uruguay 3
UZ - Uzbekistan 3
BB - Barbados 2
BY - Bielorussia 2
CY - Cipro 2
DZ - Algeria 2
GE - Georgia 2
GT - Guatemala 2
IR - Iran 2
MY - Malesia 2
NO - Norvegia 2
PA - Panama 2
UG - Uganda 2
AG - Antigua e Barbuda 1
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BH - Bahrain 1
BJ - Benin 1
BS - Bahamas 1
BZ - Belize 1
CM - Camerun 1
CW - ???statistics.table.value.countryCode.CW??? 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GH - Ghana 1
Totale 11.127
Città #
Warsaw 679
Ashburn 630
Singapore 610
Fairfield 309
Chandler 290
San Jose 287
Hong Kong 204
Dallas 176
Council Bluffs 175
Woodbridge 175
Beijing 162
Trieste 156
Houston 149
Munich 138
Ann Arbor 137
Seattle 135
Cambridge 128
Seoul 122
Los Angeles 120
Chicago 109
Hefei 109
Wilmington 104
Helsinki 95
Milan 86
Ho Chi Minh City 76
Boardman 75
London 70
Columbus 65
Rome 65
Santa Clara 62
Princeton 60
Lauterbourg 57
Hanoi 55
Jacksonville 51
New York 50
Amsterdam 44
Dublin 42
Sofia 42
Zgierz 42
Phoenix 38
Buffalo 36
Frankfurt am Main 35
Moscow 32
Izmir 30
Venice 28
Casablanca 26
Bremen 24
Grafing 24
São Paulo 24
Dearborn 23
Orem 23
Memphis 22
North Bergen 21
Palermo 21
Bern 20
Da Nang 20
Tokyo 20
Atlanta 19
Denver 19
Nuremberg 19
Lappeenranta 18
Naples 18
Redondo Beach 18
Düsseldorf 17
Salt Lake City 17
The Dalles 17
Brussels 16
Montreal 15
Toronto 15
Bologna 14
Brooklyn 14
Chennai 14
Dong Ket 14
Jinan 14
Turin 14
Vienna 14
Turku 13
Udine 13
Guangzhou 12
Des Moines 11
Elk Grove Village 11
Redwood City 11
Boston 10
Boydton 10
Florence 10
Fremont 10
Mestre 10
Poplar 10
San Diego 10
Shanghai 10
Utrecht 10
Belgrade 9
Charlotte 9
Dhaka 9
Falls Church 9
Genoa 9
Haiphong 9
Nanjing 9
Pune 9
Wroclaw 9
Totale 7.156
Nome #
A Review of the Giant Protein Titin in Clinical Molecular Diagnostics of Cardiomyopathies 513
Natural History of Dilated Cardiomyopathy in Children 441
Filamin C Truncation Mutations Are Associated With Arrhythmogenic Dilated Cardiomyopathy and Changes in the Cell–Cell Adhesion Structures 409
Genetic Risk of Arrhythmic Phenotypes in Patients With Dilated Cardiomyopathy 369
Dilated Cardiomyopathy With Mid-Range Ejection Fraction at Diagnosis: Characterization and Natural History 336
La cardiomiopatia dilatativa come malattia dinamica: storia naturale, rimodellamento inverso e stratificazione prognostica 333
High prevalence of subtle systolic and diastolic dysfunction in genotype-positive phenotype-negative relatives of dilated cardiomyopathy patients 322
Pathophysiology of dilated cardiomyopathy: from mechanisms to precision medicine 303
Hot Phases Cardiomyopathy: Pathophysiology, Diagnostic Challenges, and Emerging Therapies 288
Arrhythmic Risk Stratification in Patients With Idiopathic Dilated Cardiomyopathy 281
Chapter 13: Current Management and Treatment 278
Acute Hemodynamic Response to Cardiac Resynchronization in Dilated Cardiomyopathy: Effect on Late Mitral Regurgitation 270
Early Improvement of Functional Mitral Regurgitation in Patients With Idiopathic Dilated Cardiomyopathy 264
Comparison of Patient Characteristics and Course of Hypertensive Hypokinetic Cardiomyopathy Versus Idiopathic Dilated Cardiomyopathy 264
Chapter 5: Genetics of Dilated Cardiomyopathy: Current Knowledge and Future Perspectives 261
Genetics of Dilated Cardiomyopathy: Clinical Implications 252
Early right ventricular response to cardiac resynchronization therapy: Impact on clinical outcomes 244
Phenotypic Expression, Natural History and Risk Stratification of Cardiomyopathy Caused by Filamin C Truncating Variants 240
Genetic and Phenotypic Characterization of Nexilin (NEXN)-Related Cardiomyopathy: Results From a Multicentric Study 234
Arrhythmic risk stratification in patients with dilated cardiomyopathy and intermediate left ventricular dysfunction 233
Regional Variation in RBM20 Causes a Highly Penetrant Arrhythmogenic Cardiomyopathy 230
Role of the Electrocardiogram in Differentiating Genetically Determined Dilated Cardiomyopathy from Athlete's Heart 227
Association of Titin Variations with Late-Onset Dilated Cardiomyopathy 226
Prevalence and evolution of right ventricular dysfunction among different genetic backgrounds in dilated cardiomyopathy 224
Contemporary survival trends and aetiological characterization in non-ischaemic dilated cardiomyopathy 217
Early Arrhythmic Events in Idiopathic Dilated Cardiomyopathy 210
Insights into mildly dilated cardiomyopathy: Temporal evolution and long-term prognosis 208
Trattamento dello scompenso cardiaco con terapia genica: i risultati inattesi del trial CUPID 2 195
Impact of DCM-Causing Genetic Background on Long-Term Response to Cardiac Resynchronization Therapy 193
Clinical features and outcomes in carriers of pathogenic desmoplakin variants 192
Arrhythmic risk stratification in non-ischaemic dilated cardiomyopathy 182
Arrhythmic Risk Stratification of Carriers of Filamin C Truncating Variants 179
Prognostic Prediction of Genotype vs Phenotype in Genetic Cardiomyopathies 174
A case report of isolated cardiac light chain amyloidosis without clinically overt heart failure: an under-recognized presentation 170
Prognostic role of exercise intensity in familial Filamin C truncating variants 168
The response to cardiac resynchronization therapy in LMNA cardiomyopathy 167
Magnetic Resonance Imaging Characterization and Clinical Outcomes of Dilated and Arrhythmogenic Left Ventricular Cardiomyopathies 159
The Arrhythmic Phenotype in Cardiomyopathy 145
Risk of sudden cardiac death in New York Heart Association class I patients with dilated cardiomyopathy: A competing risk analysis 145
Whole-exome sequencing: Clinical characterization of pediatric and adult Italian patients affected by different forms of hereditary cardiovascular diseases 139
Exercise Intensity and Cardiac Disease Development in carriers of Titin variants 135
Activation of PDGFRA signaling contributes to filamin C–related arrhythmogenic cardiomyopathy 129
Fenotypic expressions and clinical manifestations of arrhythmogenic cardiomyopathy 124
Role of arrhythmic phenotype in prognostic stratification and management of dilated cardiomyopathy 122
null 121
Heart failure with reduced ejection fraction and monogenic dilated cardiomyopathy: distinct diseases? Insights from randomized controlled trials 118
Titin-related familial dilated cardiomyopathy: factors associated with disease onset 112
FLNC truncations cause arrhythmogenic right ventricular cardiomyopathy 108
Clustering in dilated cardiomyopathy at initial evaluation: An effective tool for clinical stratification 100
Prediction and prognostic role of left ventricular systolic dysfunction in family screening for dilated cardiomyopathy and non-dilated left ventricular cardiomyopathy 99
Integrated role of cardiac magnetic resonance and genetics in predicting left ventricular reverse remodelling in dilated and non-dilated cardiomyopathy 74
The heart of dystrophinopathies 67
Prognostic Role of Myocarditis-Like Episodes and Their Treatment in Patients With Pathogenic Desmoplakin Variants 63
Timing and Safety of Anticoagulation Reinitiation After Intracranial Hemorrhage in Patients With Mechanical Valves 50
Future development of arrhythmogenic risk scores in patients with heart failure and inherited dilated cardiomyopathy. A scientific statement of the Heart Failure Association of the ESC 48
What Should a Clinical Cardiologist Know About Cardiogenetics? 43
Twenty-Five-Year Follow-Up of the MDDC1 Family: A LMNA Gene Variant Associated With Dilated Cardiomyopathy With Variable Skeletal Muscle Involvement 34
Precision medicine in rare pediatric cardiomyopathies: Fiction or emerging reality? 9
Variant Site-Specific Natural History of Titin-Induced Cardiomyopathy: An International Multicenter Registry 7
Totale 11.448
Categoria #
all - tutte 30.931
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.931


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022463 0 0 25 21 32 53 24 18 55 41 53 141
2022/2023825 67 116 95 120 68 117 7 77 79 11 48 20
2023/2024595 41 33 27 32 55 77 98 87 16 18 76 35
2024/20251.682 21 57 103 107 132 139 144 130 234 244 174 197
2025/20264.683 400 273 510 449 360 343 582 187 437 524 407 211
2026/2027707 333 234 140 0 0 0 0 0 0 0 0 0
Totale 11.448